» Articles » PMID: 36557038

Albumin-Bilirubin Grade As a Novel Predictor of the Development and Short-Term Survival of Post-Banding Ulcer Bleeding Following Endoscopic Variceal Ligation in Cirrhotic Patients

Overview
Publisher MDPI
Specialty General Medicine
Date 2022 Dec 23
PMID 36557038
Authors
Affiliations
Soon will be listed here.
Abstract

Background and Objectives: Endoscopic variceal ligation (EVL) is the primary and secondary treatment for acute esophageal variceal bleeding. Post-banding ulcer bleeding (PBUB) may lead to bleeding episodes following EVL, increasing mortality. The aim of this study was to evaluate the risk factors for PBUB and predict the 6-week mortality risk after PBUB. Materials and Methods: We retrospectively analyzed the data collected from cirrhotic patients with EVL from 2015 to 2017. The incidence of PBUB and the 6-week mortality rate were evaluated. Risk factors for PBUB and predictive factors for mortality after PBUB were analyzed. Results: A total of 713 patients were enrolled in this study. Among the studied subjects, the incidence of PBUB was 5.8% (N = 41). The 6-week mortality rate was 63.4% (26/41). In multivariate analysis, MELD score ≥20 (OR: 3.77, 95% CI: 1.94−7.33, p < 0.001), ALBI score of 3 (OR: 2.67, 95% CI: 1.34−5.3, p = 0.005) and the presence of gastric varices (OR: 2.1, 95% CI: 1.06−4.16, p = 0.03) were associated with the development of PBUB. Patients with ALBI grade 3 (OR: 4.8, 95% CI: 1.18−19.6, p = 0.029) and Child-Pugh scores B and C (OR: 16.67, 95% CI: 1.75−158.1, p = 0.014) were associated with 6-week mortality after PBUB. Conclusions: PBUB is a complication with low incidence but increased mortality following EVL. The ALBI grade is a useful score to predict not only the development of PBUB but also the 6-week mortality after PBUB.

Citing Articles

Prognostic value of albumin-bilirubin grade in patients with cholangiocarcinoma: a systematic review and meta-analysis.

Omouri-Kharashtomi M, Alemohammad S, Moazed N, Afzali Nezhad I, Ghoshouni H BMC Gastroenterol. 2025; 25(1):19.

PMID: 39815213 PMC: 11736951. DOI: 10.1186/s12876-025-03596-6.


Relationship between platelet-to-lymphocyte ratio and early rebleeding after endoscopic variceal ligation: a bicenter retrospective study.

Wang W, Ju H, Zhang W, Ma C, He C Ann Med. 2024; 56(1):2400315.

PMID: 39239880 PMC: 11382711. DOI: 10.1080/07853890.2024.2400315.


Association of easy albumin-bilirubin score with increased mortality in adult trauma patients.

Hsu S, Rau C, Tsai C, Chou S, Su W, Hsieh C Front Surg. 2024; 11:1280617.

PMID: 38721021 PMC: 11076689. DOI: 10.3389/fsurg.2024.1280617.


Role of albumin-bilirubin score in non-malignant liver disease.

Xu S, Yang F, Ge N, Guo J, Sun S World J Gastroenterol. 2024; 30(9):999-1004.

PMID: 38577181 PMC: 10989493. DOI: 10.3748/wjg.v30.i9.999.


Albumin‑bilirubin grade and INR for the prediction of esophagogastric variceal rebleeding after endoscopic treatment in cirrhosis.

Li F, Wang T, Liang J, Qian B, Tang F, Gao Y Exp Ther Med. 2023; 26(5):501.

PMID: 37822588 PMC: 10562956. DOI: 10.3892/etm.2023.12200.


References
1.
Vanbiervliet G, Giudicelli-Bornard S, Piche T, Berthier F, Gelsi E, Filippi J . Predictive factors of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case-control study. Aliment Pharmacol Ther. 2010; 32(2):225-32. DOI: 10.1111/j.1365-2036.2010.04331.x. View

2.
Drolz A, Seiz O, Groth S, Vettorazzi E, Horvatits T, Wehmeyer M . Risk factors associated with bleeding after prophylactic endoscopic variceal ligation in cirrhosis. Endoscopy. 2020; 53(3):226-234. DOI: 10.1055/a-1214-5355. View

3.
Garcia-Tsao G, Abraldes J, Berzigotti A, Bosch J . Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2016; 65(1):310-335. DOI: 10.1002/hep.28906. View

4.
Nijhawan S, Rai R, Nepalia S, Pokharana D, Bharagava N . Natural history of postligation ulcers. Am J Gastroenterol. 1994; 89(12):2281-2. View

5.
Hiraoka A, Michitaka K, Kumada T, Izumi N, Kadoya M, Kokudo N . Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function. Liver Cancer. 2017; 6(4):325-336. PMC: 5704689. DOI: 10.1159/000479984. View